Product Information
Macugen (pegaptanib sodium) is the newest treatment available for wet age-related macular degeneration. Macugen (pegaptanib sodium) is the only drug therapy approved by the FDA for patients with all types of wet AMD. Macugen (pegaptanib sodium) is effective at slowing vision loss, but it's still important to detect macular degeneration as early as possible to help preserve vision.Macugen (pegaptanib sodium) works differently from other wet AMD therapies because it blocks an essential signal that causes abnormal blood vessels to grow and leak. Macugen (pegaptanib sodium) is not a cure, but it can help to slow further vision loss and also to help preserve what vision you currently have. Macugen (pegaptanib sodium) is administered into the eye every 6 weeks. Your doctor will determine how long you'll need treatment. Be sure to attend follow-up appointments for eye exams and Macugen (pegaptanib sodium) treatments according to your doctor's recommendations
Age-related macular degeneration (AMD) is an eye condition that affects the back of your eye, called the retina. At the center of the retina is the macula. The macula lets you see objects straight ahead, which is called central vision. Macular degeneration damages the macula, which causes you to lose your central vision.
Macugen (pegaptanib sodium) should be stored in the refrigerator at 2 to 8 degrees celcius.
